文献速递呼吸道感染

成人社区获得性肺炎住院患者10年肺炎链球菌肺炎趋势及血清型3的作用

Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013-2023) and the role of serotype 3.
PubMed 文献 · Thorax · 2025-01-17

该前瞻性队列研究纳入2013年9月至2023年5月5186例成人社区获得性肺炎住院患者,采用24价尿抗原检测血清型。结果显示肺炎链球菌肺炎占42.2%,其比例从36.4%升至66.9%(p<0.001),血清型3占比从13.4%升至48.8%。血清型3与高龄、男性(aOR 2.22)及慢性肾病(aOR 1.81)相关,但未观察到与严重程度、重症监护需求、死亡率或再入院相关。

要点

  • 成人CAP中肺炎链球菌占比10年间从36.4%升至66.9%。
  • 血清型3占比从13.4%升至48.8%,成为主要血清型。
  • 血清型3与高龄、男性及慢性肾病相关,但未增加疾病严重程度。

核心结论

  • 血清型3是成人肺炎链球菌CAP的主要血清型且占比持续上升,与缺乏群体保护一致。

研究设计与样本

  • 前瞻性队列研究,纳入2013年9月至2023年5月成人CAP住院患者5186例,采用24价血清型特异性尿抗原检测。

主要发现

  • 5186例CAP患者中2193例(42.2%)为肺炎链球菌肺炎。
  • 肺炎链球菌CAP比例从2013年36.4%升至2023年66.9%(p<0.001)。
  • 血清型3占比从2013年13.4%升至2023年48.8%。
  • 血清型3肺炎与高龄(p<0.001)、男性(aOR 2.22,95%CI 1.64-3.01)及慢性肾病(aOR 1.81,95%CI 1.09-3.02)相关。
  • 血清型3肺炎未观察到与严重程度、重症监护需求、死亡率或再入院相关。

临床怎么用

  • 在成人CAP经验性诊治中需关注肺炎链球菌,尤其血清型3的持续流行。
  • 对高龄、男性及慢性肾病患者应警惕血清型3肺炎链球菌感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With higher valency pneumococcal vaccines on the horizon and new adult immunisation strategies under discussion, we aimed to evaluate the contribution of individual pneumococcal serotypes to the burden of pneumococcal community-acquired pneumonia (CAP). Over 10 years, trends in pneumococcal pneumonia epidemiology in adults hospitalised with CAP were assessed. The risk factors and severity associated with serotype 3 were examined. METHODS: We conducted a prospective cohort study of adults hospitalised with CAP between September 2013 and May 2023. Pneumococcal serotypes were identified using a serotype-specific 24-valent urinary-antigen assay. Trends in the proportion of CAP due to pneumococcus and causative serotypes were compared prepandemic and postpandemic. Risk factors and severity of serotype 3 pneumonia were compared with other serotypes using logistic regression. RESULTS: Of 5186 patients with CAP, 2193 (42.2%) had pneumococcal pneumonia. The proportion of CAP due to pneumococcus increased across all ages between 2013 and 2023 (36.4%-66.9%, p<0.001). The proportion due to serotype 3 increased significantly from 13.4% (2013) to 48.8% (2023). Serotype 3 pneumonia in adults was associated with older age (p<0.001), male sex (adjusted OR (aOR) 2.22, 95% CI 1.64 to 3.01) and chronic renal disease (aOR 1.81, 95% CI 1.09 to 3.02). Serotype 3 pneumonia was not observed to be associated with severity, critical care requirement, mortality or readmission. INTERPRETATION: Serotype 3 is the predominant serotype in adult pneumococcal CAP and has been increasing despite a mature infant pneumococcal immunisation programme, consistent with a lack of herd protection for this serotype.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Lansbury, McKeever, Lawrence, et al. Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013-2023) and the role of serotype 3. Thorax. 2025. PMID: 39667904. doi:10.1136/thorax-2024-221976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。